Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML

Mikkael A. Sekeres,Justin Watts,Atanas Radinoff,Montserrat Arnan Sangerman,Marco Cerrano,Patricia Font Lopez,Joshua F. Zeidner,Maria Diez Campelo,Carlos Graux,Jane Liesveld,Dominik Selleslag,Nikolay Tzvetkov,Robert J. Fram,Dan Zhao,Jill Bell,Sharon Friedlander,Douglas V. Faller,Lionel Adès

LEUKEMIA（2021）

引用 67|浏览7

暂无评分

关键词

Acute myeloid leukaemia,Myelodysplastic syndrome,Randomized controlled trials,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要